Gabapentin Is a First Line Drug for the Treatment of Neuropathic Pain in Spinal Cord Injury

Spine

Volumn 29, Issue 7, 2004, Pages 743-751

  Levendoǧlu, Funda ^a   Öǧün, Cemile Ö ^a   Özerbil, Önder ^a   Öǧün, Tunç C ^a   Uǧurlu, Hatice ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Gabapentin; Neuropathic pain; Spinal cord injury

Indexed keywords

GABAPENTIN; PLACEBO;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FEMALE; HEADACHE; HUMAN; MALE; MUSCLE TWITCH; MUSCLE WEAKNESS; NAUSEA; NEUROPATHIC PAIN; PARAPLEGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SPINAL CORD INJURY; TITRIMETRY; VERTIGO; VISUAL IMPAIRMENT; VOMITING;

ACETIC ACIDS; ADULT; AGED; AMINES; ANALGESICS; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; SLEEP; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 1842616051     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000112068.16108.3A     Document Type: Article

References (44)

1. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001; 17:284-95.
2. Belgrade MJ. Following the clues to neuropathic pain. Postgrad Med 1999; 106:127-40.
3. Warms CA, Turner JA, Marshall MH, et al. Treatments for chronic pain associated with spinal cord injuries: many are tried, few are helpful. Clin J Pain 2002;18:154-63.
4. Fenollosa P, Pallares J, Cervera J, et al. Chronic pain in the spinal cord injured: statistical approach and pharmacological treatment. Paraplegia 1993;31:722-9.
5. Putzke DJ, Richards SJ, Kezar L, et al. Long term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin J Pain 2002;18: 116-21.
6. Sandford PR, Lindblom LB, Haddox D. Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury. Arch Phys Med Rehabil 1992;73:300-301.
7. Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 2002;25:100-5.
8. To TP, Lim TC, Hill ST, et al. Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord 2002;40:282-5.
9. Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil 1979;60:605-9.
10. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-6.
11. Feinberg SD. Prescribing analgesics: how to improve function and avoid toxicity when treating chronic pain. Geriatrics 2000;55:44-62.
12. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
13. Backonja MM. Anticonvulsants for neuropathic pain syndromes. Clin J Pain 2000;16:567-72.
14. Beydoun A. Postherpetic neuralgia: role of gabapentin and other treatment modalities. Epilepsia 1999;40(suppl 6):51-6.
15. Ahn SH, Park HW, Lee BS, et al. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Spine 2003;28:341-6.
16. Serpell MG. Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo controlled trial. Pain 2002;99:557-66.
17. Feldman EL, Stevens MJ, Greene DA. Treatment of diabetic neuropathy. In: Mazzafferi EL, Bar RS, Kreisberg RE, eds. Advances in Endocrinology and Metabolism. St. Louis; Mosby-Year Book Inc; 1994:396-428.
18. Turner JA, Cardenas DD. Chronic pain problems in individuals with spinal cord injuries. Semin Clin Neuropsychiatry 1999;4:186-94.
19. Turner JA, Cardenas DD, Warms CA, et al. Chronic pain associated with spinal cord injuries: a community survey. Arch Phys Med Rebabil 2001;82: 501-7.
20. Davidoff G, Roth E, Guarracini M, et al. Function-limiting dysesthetic pain syndrome among traumatic spinal cord injury patients: a cross-sectional study. Pain 1987;29:39-48.
21. Mariano AJ. Chronic pain and spinal cord injury. Clin J Pain 1992;8:87-92.
22. Rintala DH, Loubser PG, Castro J, et al. Chronic pain in a community-based sample of men with spinal cord injury. Arch Phys Med Rehabil 1998;79: 604-14.
23. Stormer S, Gerner HJ, Gruninger W, et al. Chronic pain/dysesthesia in spinal cord injury patients: results of a multicenter study. Spinal Cord 1997;35: 446-55.
24. Melzack R, Katz J. The McGill Pain Questionnaire: appraisal and current status. In: Turk DC, Melzack R, ed. Handbook of Pain Assessment. New York, NY: Guilford Press; 1992:152-68.
25. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, ed. Handbook of Pain Assessment. New York, NY: Guilford Press; 1992:135-51.
26. Price DD, Harkins SW. Psychophysical approaches to pain measurement and assessment. In: Turk DC, Melzack R, ed. Handbook of Pain Assessment. New York, NY: Guilford Press; 1992:111-34.
27. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
28. Houtchens MK, Richert JR, Sami A, et al. Open label gabapentin treatment of pain in multiple sclerosis. Mult Scler 1997;3:250-3.
29. Kabadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: a case report. Arch Phys Med Rebabil 2000;81:1439-41.
30. Bradley S, Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Rehabil Med 1997;48:332-7.
31. Berthold B. Methods of testing pain mechanism in normal man. In: Wall P, Melzack R, ed. Textbook of Pain. London: Churchill Livingstone; 1994: 186-94.
32. Fairholm D. Managing pain. In: Zejdlik CP, ed. Management of Spinal Cord Injury. Boston, MA: Jones and Barlett; 1991:593-601.
33. Roth EJ. Practical pain management strategies. In: Yarkony GM, ed. Spinal Cord Injury: Medical Management and Rehabilitation. Gaithersburg, MD: Aspen; 1994:159-66.
34. Segatore M. Deafferentation pain after spinal cord injury: part II. Management. SCI Nurs 1992;9:72-8.
35. Watson CPN. The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain 2000;16:49-55.
36. Thomas RJ. Excitatory amino acids in health and disease. J Am Geriatr Soc 1995;43:1279-89.
37. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998;280:1837-42.
38. Tunks E. Pain in spinal cord injured patients. In: Bloch RF, Basbaum M, eds. Management of Spinal Cord Injuries. Baltimore, MD: Williams and Wilkins; 1986:180-211.
39. Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain 1996;68:185-94.
40. Yezierski RP. Pain following spinal cord injury: pathophysiology and central mechanisms. Prog Brain Res 2000;429-49.
41. Mercadante S. Gabapentin in spinal cord injury pain. Pain Clinic 1998;10: 203-6.
42. Salas MM, Barber DB, Rogers SJ, et al. Gabapentin and neuropathic pain in spinal cord injury: a retrospective study. J Spinal Cord Med 1999;22:364.
43. McQuay HJ, Trainer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
44. Samkoff LM, Daras M, Tuchman AJ, et al. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997;49: 304-5.